kuwanon H: a non-peptide bombesin receptor antagonist; RN refers to (1S-(1alpha,5alpha,6beta))-isomer; structure given in first source
kuwanone H : A tetrahydroxyflavone isolated from the plant species of the genus Morus.
ID Source | ID |
---|---|
PubMed CID | 5281668 |
CHEMBL ID | 506234 |
CHEBI ID | 6147 |
SCHEMBL ID | 150578 |
MeSH ID | M0250709 |
Synonym |
---|
gtpl622 |
kuwanone h |
76472-87-2 |
kuwanon h |
chebi:6147 , |
CHEMBL506234 |
kumanon h |
8-[6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one |
4h-1-benzopyran-4-one, 8-(6-(2,4-dihydroxy-3-(3-methyl-2-butenyl )benzoyl)-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, (1s-(1alpha,5alpha,6beta))- |
nsc 356889 |
8-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one |
8-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one |
SCHEMBL150578 |
8-{(1r,2s,3s)-2-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-2',4'-dihydroxy-5-methyl[1,2,3,6-tetrahydro[1,1'-biphenyl]]-3-yl}-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4h-1-benzopyran-4-one |
moracenin a |
8-((1r,2s,3s)-2-(2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl)-2',4'-dihydroxy-5-methyl-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4h-chromen-4-one |
AKOS037515236 |
CS-0023002 |
HY-N2600 |
MS-31352 |
DTXSID301318627 |
kuwanonh |
2-(2,4-bis(oxidanyl)phenyl)-8-((1s,5s,6r)-5-(2,4-bis(oxidanyl)phenyl)-3-methyl-6-(3-(3-methylbut-2-enyl)-2,4-bis(oxidanyl)phenyl)carbonyl-cyclohex-2-en-1-yl)-3-(3-methylbut-2-enyl)-5,7-bis(oxidanyl)chromen-4-one |
4h-1-benzopyran-4-one, 8-[6-[2,4-dihydroxy-3-(3-methyl-2-butenyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, [1s-(1alpha,5alpha,6beta)]- |
4h-1-benzopyran-4-one, 8-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methyl-2-buten-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-buten-1-yl)- |
8-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methyl-2-buten-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-buten-1-yl)-4h-1-benzopyran-4-one |
822Q5M4B5D |
Role | Description |
---|---|
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
tetrahydroxyflavone | Any hydroxyflavone carrying four hydroxy substituents. |
resorcinols | Any benzenediol in which the two hydroxy groups are meta to one another. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID332856 | Inhibition of 12-hydroxy-5,8,10-heptadecatrienoic acid formation in Wistar King platelets | |||
AID332860 | Stimulation of 12-hydroxy-5,8,10,14-eicosatetraenoic acid formation in Wistar King platelets at 1 mM | |||
AID332851 | Stimulation of 12-hydroxy-5,8,10,14-eicosatetraenoic acid formation in Wistar King platelets at 10 uM | |||
AID332853 | Stimulation of 12-hydroxy-5,8,10,14-eicosatetraenoic acid formation in Wistar King platelets | |||
AID332858 | Inhibition of thromboxane B2 formation in Wistar King platelets | |||
AID1346497 | Rat BB1 receptor (Bombesin receptors) | 1995 | Biochemical and biophysical research communications, Aug-15, Volume: 213, Issue:2 | Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry. |
AID1346516 | Mouse BB2 receptor (Bombesin receptors) | 1995 | Biochemical and biophysical research communications, Aug-15, Volume: 213, Issue:2 | Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.62) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (28.57%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (71.43%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |